Results 21 to 30 of about 185,865 (259)

RTEL1 gene polymorphisms and neuroblastoma risk in Chinese children

BMC Cancer, 2023
Background Neuroblastoma, a neuroendocrine tumor originating from the sympathetic ganglia, is one of the most common malignancies in childhood. RTEL1 is critical in many fundamental cellular processes, such as DNA replication, DNA damage repair, genomic ...
Ting Zhang, Chunlei Zhou, Jiejie Guo, Jiamin Chang, Haiyan Wu, Jing He   +5 more
doaj   +1 more source

Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma : a report from the HR-NBL1/SIOPEN study [PDF]

, 2020
PURPOSE To evaluate the impact of surgeon-assessed extent of primary tumor resection on local progression and survival in patients in the International Society of Pediatric Oncology Europe Neuroblastoma Group High-Risk Neuroblastoma 1 trial. PATIENTS AND
Metzelder, Martin, Beck-Popovic, M., Elliott, Martin, de Lacerda, Ana Forjaz, Ash, S., Malis, Josef, Beck-Popovic, Maja, Papadakis, Vassilios, Pötschger, Ulrike, Bjørnland, Kristin, Joseph, J.M., Godzinski, Jan, Schroeder, Henrik, Rasmussen, L., Avanzini, S., Stenman, J., McHugh, K., Luksch, Roberto, Owens, C., Irtan, S., Cecchetto, Giovanni, Stenman, Jakob, Freud, Enrique, Bysiek, Adam, Gaze, Mark, Trahair, Toby, De Lacerda, Ana, Rasmussen, Lars, Irtan, Sabine, Ash, Shifra, Ruud, Ellen, McHugh, Kieran, Laureys, G., Monclair, Tom, Elliott, M., Ambros, Peter, Cecchetto, G., Ruud, E., Pötschger, U., Rygl, M., Pearson, Andrew, Laureys, Geneviève, Metzelder, M., Monclair, T., Papadakis, V., Ladenstein, R.L., Ladenstein, Ruth Lydia, Freud, E., Rygl, Michal, Castel, Victoria, Pearson, Andrew D.J., Björnland, K., Holmes, K., Pearson, Andrew D. J., Castel, V., Joseph, Jean-Marc, Gomez-Chacon, Javier, Owens, Cormac, Gaze, M.N., Trahair, T., Ladenstein, Ruth, Matthyssens, L.E., Bysiek, A., Luksch, R., Holmes, Keith, Balwierz, Walentyna, Squire, R., Avanzini, Stefano, Valteau-Couanet, Dominique, Matthyssens, Lucas E, Ambros, Peter F., for the International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN), [missing], Godzinski, J., Malis, J., Ambros, P.F., Joseph, Jean Marc, Schroeder, H., Squire, Roly, Sarnacki, Sabine, Gomez-Chacon, J., Forjaz de Lacerda, Ana, Matthyssens, Lucas E., Pearson, ADJ, Björnland, Kristin, Sarnacki, S., Gaze, Mark N., Valteau-Couanet, D., Forjaz de Lacerda, A., Matthyssens, Lucas, Balwierz, W., Avanzini S, Castel V, Björnland K, Poetschger, U, Rasmussen L, Cecchetto G, Freud, E, Valteau-Couanet D, Gomez-Chacon J, Trahair T, Freud E, Forjaz de Lacerda A, Ruud E, Irtan S, Schroeder H, Owens C, Metzelder M, Godzinski J, Pötschger U, Squire R, Ladenstein RL, Gomez-Chacon, J, Papadakis V, Rygl M, Sarnacki, S, Luksch R, Elliott M, Matthyssens, LE, Squire, R, Bysiek, A, Balwierz W, Monclair T, Pearson ADJ, Stenman J, Ambros PF, Beck-Popovic M, Gaze MN, Bysiek A, Ash S, Sarnacki S, Holmes, K, Cecchetto, G, Matthyssens LE, Laureys G, Joseph JM, Holmes K, Malis J, McHugh K   +137 more
core   +1 more source

EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.

PLoS ONE, 2021
Investigation of the mechanisms responsible for aggressive neuroblastoma and its poor prognosis is critical to identify novel therapeutic targets and improve survival.
Laura V Bownes, Adele P Williams, Raoud Marayati, Laura L Stafman, Hooper Markert, Colin H Quinn, Nikita Wadhwani, Jamie M Aye, Jerry E Stewart, Karina J Yoon, Elizabeth Mroczek-Musulman, Elizabeth A Beierle   +11 more
doaj   +1 more source

Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy [PDF]

, 2011
Background: The treatment of high-risk neuroblastoma patients consists of multimodal induction therapy to achieve remission followed by consolidation therapy to prevent relapses. However, the type of consolidation therapy is still discussed controversial.
Berthold, Frank, Berthold Frank, Andreas Faldum, Martin Schrappe, Frank Berthold, Handgretinger Rupert, Simon, Thorsten, Barbara Hero, Thomas Klingebiel, Handgretinger, Rupert, Faldum Andreas, Simon Thorsten, Hero, Barbara, Schrappe, Martin, Klingebiel Thomas, Schrappe Martin, Thorsten Simon, Rupert Handgretinger, Hero Barbara, Faldum, Andreas, Klingebiel, Thomas   +20 more
core   +2 more sources

Selection of a highly invasive neuroblastoma cell population through long-term human cytomegalovirus infection. [PDF]

, 2012
The human cytomegalovirus (HCMV) is suspected to increase tumour malignancy by infection of cancer and/or stroma cells (oncomodulation). So far, oncomodulatory mechanisms have been attributed to the presence of HCMV and direct action of its gene products
Steinberger, D., Griffin, D.K., Breitling, Rainer, Barth, Susanne, Breitling, R., Cinatl, J., Doerr, Hans Wilhelm, Rothweiler, Florian, Steinberger, D, Hackmann, Karl, Rothweiler, F., Schröck, E, Schröck, Evelin, Hackmann, K., Michaelis, Martin, Cinatl, Jindrich, Bruch, J., Schröck, E., Doerr, H. W., Hackmann, K, Steinberger, Daniela, Barth, S., Cinatl Jr., J., Griffin, D. K., Michaelis, M., Bruch, James C., Cinatl, Jaroslav, Doerr, H.W., Bruch, Jochen, Griffin, Darren K., Breitling, R.; id_orcid   +30 more
core   +1 more source

Anesthetic management of an infant with giant abdominal neuroblastoma

Brazilian Journal of Anesthesiology, 2017
Neuroblastoma is the most common, non-central nervous system tumor of childhood. It has the potential to synthesize catecholamines. However, the presences of hypertension are uncommon.
Manuel Ángel Gómez-Ríos, Federico Curt Nuño, Purísima Barreto-Calvo   +2 more
doaj   +1 more source

Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression

BMC Cancer, 2009
Background Neuroblastoma is a pediatric tumor of neural crest cells that is clinically characterized by its variable evolution, from spontaneous regression to malignancy.
Gingras Denis, Barrette Stéphane, Ohta Shigeru, Sartelet Hervé, Nyalendo Carine, Béliveau Richard   +5 more
doaj   +1 more source

On the cytotoxicity of HCR-NTPase in the neuroblastoma cell line SH-SY5Y [PDF]

, 2009
Pasdziernik M, Kaltschmidt B, Kaltschmidt C, Klinger C, Kaufmann M. On the cytotoxicity of HCR-NTPase in the neuroblastoma cell line SH-SY5Y. BMC Research Notes. 2009;2(1):102.Background: The human cancer-related nucleoside triphosphatase (HCR-NTPase) is
Klinger, Claudia, Kaltschmidt Barbara, Kaltschmidt Christian, Kaltschmidt, Christian, Kaufmann Michael, Kaufmann, Michael, Pasdziernik Markus, Pasdziernik, Markus, Kaltschmidt, Barbara, Klinger Claudia   +9 more
core   +1 more source

A Neuroblastoma Case Presenting with Seizures Resistant to Anti-Epileptic Treatments [PDF]

, 2022
Seizure is a rare symptom of paraneoplastic syndrome seen in neuroblastoma without a previous history. A 4-month-old male patient who was followed up with a preliminary diagnosis of an adrenal mass in pediatric oncology was admitted to hospital with a ...
Sibğatullah Ali Orak, Çisil Çerçi Kubur, Aslı Kübra Atasever, ASLI KUBRA ATASEVER, Celil Yılmaz, Muzaffer Polat, POLAT, MUZAFFER, Kubur Ç.Ç., Polat M., Atasever, Aslı Kübra, Yılmaz C., Yılmaz, Celil, Kubur, Çisil Çerçi, Orak S.A., Atasever A.K., Orak, Sibğatullah Ali   +15 more
core   +1 more source

Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model

OncoImmunology, 2020
Neuroblastoma is a childhood malignancy and in the majority of patients, the primary tumor arises in one of the adrenal glands. Neuroblastoma cells highly express the disialoganglioside GD2, which is the primary target for the development of ...
Renske J. E. van den Bijgaart, Michiel Kroesen, Ingrid C. Brok, Daphne Reijnen, Melissa Wassink, Louis Boon, Peter M. Hoogerbrugge, Gosse J Adema   +7 more
doaj   +1 more source